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In the present pilot study (56 patients), some red blood cell parameters in samples from patients with metabolic syndrome and
subclinical atherosclerosis, but without any sign of coronary artery disease, have been analyzed. The main goal of this work
was to determine, in this preclinical state, new peripheral gender-associated bioindicators of possible diagnostic or prognostic
value. In particular, three diﬀerent “indicators” of red blood cell injury and aging have been evaluated: glycophorin A, CD47,
and phosphatidylserine externalization. Interestingly, all these determinants appeared signiﬁcantly modiﬁed and displayed gender
diﬀerences. These ﬁndings could provide novel and useful hints in the research for gender-based real-time bioindicators in the
progression of metabolic syndrome towards coronary artery disease. Further, more extensive studies are, however, necessary in
order to validate these ﬁndings.
1.Introduction
Metabolic syndrome (MetS) is a cluster of risk factors for
atherosclerosis, including insulin resistance, hypertension,
glucose intolerance, hypertriglyceridemia, and low high-
density lipoprotein-cholesterol (HDL-C) levels [1]. Aﬀected
patients have a signiﬁcantly increased risk of developing
atherosclerotic disease, diabetes, and cardiovascular disease
(CVD). This is probably due to a blood hypercoagulability as
wellastoendothelialcellactivation.Ithasbeenhypothesized
that the hypercoagulability state could predispose patients to
venous thromboembolism [2].
Several epidemiological studies, the Framingham, in
particular [3], have investigated into the evolution of car-
diovascular disease hypothesizing the presence of a gender
diﬀerence in the pathogenetic and progression determinants
detectable in men and women. For instance, women were
found to outlive men and to experience fewer atherosclerotic
cardiovascular events, with an incidence lagging behind that
i nm e nb y1 0t o2 0y e a r s[ 4]. This gap in incidence closes
with advancing age, when CVD becomes the leading cause of
death in women as well as in men [5, 6]. In consideration
of the high incidence of morbidity and mortality, due
to CVD, and of the paucity of well-established gender-
associated markers, further studies focused at identifying
novel bioindicators should be considered as mandatory.
On these bases, a pilot study has been conducted in a low
number of patients with MetS of both sexes and subclinical
atherosclerosis with the aim to identify innovative peripheral
blood biomarker in this preclinical phase [7]. We focused
our attention on the red blood cell (RBC) as a candidate
possibly implicated in these pathologic conditions. RBCs are
peculiar cells aimed at the delivery of oxygen and nitric oxide
totheperipheryandcarbondioxidetothelungs.Inaddition,
they also exert, under physiological conditions, a scavenging
activity towards reactive oxygen and nitrogen species often
overproduced in morbidity states, for example, in inﬂamed
tissues. Their deformability, essential for their circulation in2 International Journal of Cell Biology
small blood vessels, is an important prerequisite for such
vascular“antioxidant”functions.Conversely,whentheredox
state of RBCs is altered, erythrocytes can turn out to be a
sourceofreactivespecies,and,consequently,itstypicalstruc-
tural and functional features are lost [8, 9]. Importantly, the
oxidatively modiﬁed erythrocyte increases its aggregability
andadhesivenesstotheendotheliumandtootherbloodcells,
thus contributing to vascular damage. In addition, CVD risk
factors,namely,insulinresistance,obesity,andhypertension,
all share a common abnormal ion proﬁle in RBCs. This
might help to explain their frequent clinical coexistence.
Speciﬁcally, it has been hypothesized that RBC intracellular
pH levels are lower and inversely linked to both body
mass index (BMI) and fasting insulin concentrations either
in normotensive or hypertensive individuals. Moreover,
ionic imbalance, for example, of intracellular potassium,
magnesium,andcalcium,candecreaseintracellularpHlevels
also resulting in a reduced GSH/GSSG ratio [10]. In this
work, three diﬀerent putative “indicators” of RBC injury and
aging have been evaluated: glycophorin A (GA), CD47, and
phosphatidylserine (PS). The ﬁrst is a glycoprotein that is
widely expressed at the surface of RBC and is downregulated
during senescence [11]; the second, CD47, as for other cells,
is an integrin-associated protein that acts as a “marker of
self” [12]; the third is a phospholipid localized to the inner
leaﬂet of the plasma membrane, which is externalized to the
outer leaﬂet during cell remodeling leading to cell death, for
example, by eryptosis [13, 14]. Notably, it has been reported
that phosphatidylserine-exposing RBCs may adhere to the
vascular walls [14] and may interfere with microcirculation
as it has been proposed to occur in the metabolic syndrome
[9]. Importantly, GA loss, PS externalization (evaluated in
terms of positivity to its ligand: annexin V), and reduced
expression of CD47, respectively, have been reported as
critical events responsible for the removal of RBCs at the end
of their lifespan [15–17].
2. Patientsand Methods
2.1. Study Population. The study population consisted of 56
ambulatory subjects with MetS (31 men and 25 women,
aging 50–70 years) and 40 age-matched healthy donors
(HDs) (22 men and 18 women). All patients and HDs
were Caucasian. All study subjects underwent a complete
cardiovascular evaluation which has included: history and
physical examination, heart rate, blood pressure, fasting
serum glucose; fasting plasma lipids, Fibrinogen, CRP, com-
prehensive two-dimensional echocardiogram, carotid echo-
colorDopplerandexerciseECGtesting.Healthydonorswere
identiﬁed on the basis of the absence of CVD risk factors and
a completely normal CVD screening.
MetS was diagnosed according to the amended National
Cholesterol Education Program’s Adult Treatment Panel III
(ATP-III) Guidelines in individuals meeting three or more
of the criteria reported elsewhere [1]. Healthy donors were
identiﬁed on the basis of the absence of CVD risk factors
and a completely normal CVD screening. We included in
the study (i) patients with an increased (N1mm) carotid
intima-media thickness (IMT), but in the absence of known
or suspected coronary artery disease (CAD), and (ii) only
women in postmenopausal and without hormone replace-
ment therapy. The patient characteristics have been reported
in Table 1.
Patients with previous myocardial infarction, previous
coronary artery by-pass graft, coronary angioplasty or posi-
tive exercise ECG testing, depression, inﬂammatory diseases,
and ACEI treatment were excluded from the study. The
nature and the purpose of the study were explained to all
participants who gave their informed consent following the
rules of good medical practice. This study was approved
by the Institutional Review Board of “Sapienza” University
of Rome (Italy). The investigation was conformed to the
principles outlined in the Declaration of Helsinki.
2.2. Isolation of Erythrocytes. Human erythrocyte suspen-
sions were prepared from fresh venous blood collected as
previously reported [11].
2.3. Analysis of the Redox Balance in RBCs. For intracellular
ROS production, RBCs (5 × 105 cells) were incubated in
Hanks’ balanced salt solution (HBSS, pH 7.4) containing
dihydrorhodamine 123 (DHR 123, Molecular Probes, USA).
Intracellular content of reduced thiols was explored by
using 5-chloromethylﬂuoresceindiacetate (CMFDA, Molec-
ular Probes). Samples were then analyzed with a FACScan
ﬂow cytometer (Becton Dickinson, Mountain View, Calif,
USA). The median values of ﬂuorescence intensity his-
tograms were used to provide semiquantitative evaluation
of reduced thiols content and reactive oxygen species (ROS)
production.
2.4. Evaluation of RBC Injury. Quantitative evaluation of
RBCs with phosphatidylserine externalization [11]w a sp e r -
formed by ﬂow cytometry after double staining using FITC-
conjugated annexin V and 0.05% Trypan blue for 10min
at room temperature and analyzed by ﬂuorescence-activated
cell sorting (FACS) in the FL3 channel to determine the
percentage of dead cells.
2.5. Quantitative and Qualitative RBC Protein Analyses. For
glycophorin A detection, RBCs were stained with anti-
glycophorin A (Saint Louis, Mo, USA) monoclonal anti-
bodies and subsequently incubated with anti-mouse IgG-
ﬂuorescein-linked whole antibodies (Sigma). For CD47,
RBCs were ﬁxed with 4% paraformaldehyde, permeabilized
with 0.5% Triton X-100 (Sigma Chemical Co, Mo, USA),
stainedwithmonoclonalanti-CD47(SantaCruzBiotechnol-
ogy, CA, USA), and subsequently incubated with antimouse
IgG-ﬂuorescein-linked whole antibody (Sigma). Finally, all
the samples were analyzed with a FACScan ﬂow cytometer or
observed with a Nikon Microphot ﬂuorescence microscope.
2.6. Morphometric Analyses. Whole blood from MetS
patients and healthy donors was stripped on the slide, dried
at room temperature, and observed by light or diﬀerential
interference contrast (DIC) microscopy. Altered erythrocyte
shape was evaluated by counting at least 500 cells (50 RBCsInternational Journal of Cell Biology 3
Table 1: Patients’ characteristics. Signiﬁcant diﬀerences are in bold. Data are the mean ± SD of 56 MetS patients (31 male and 25 female)
and 40 HD (22 male and 18 female).
Variables 56 MetS
(M = 31 F = 25)
40 HD
(M = 22 F = 18) P-values
Risk factors
Body mass index (Kg/m2) 31.98 ±4.84 21.05 ±2.01 0.0001
Waist circumference (cm) 112.7 ±14.98 71.79 ±6.22 0.0001
Systolic blood pressure (mmHg) 134.57 ±17.7 120.63 ± 80 . 0 3
Diastolic blood pressure (mmHg) 84.13 ±9.37 74.95 ±5.68 0.001
Glucose (mg/dl) 122.71 ±34.87 63.84 ±9.38 0.001
Total cholesterol (mg/dl) 197.62 ± 38.83 178.39 ± 20.23 0.15
LDL-cholesterol (mg/dl) 125.4 ± 36.08 114.27 ± 28.51 0.31
HDL-cholesterol (mg/dl) 44.41 ± 8.47 47.09 ± 8.8 0.78
Triglyceride (mg/dl) 144.8 ± 72.28 118.94 ± 48.96 0.26
Family history of CAD 12 (50%) 4 (21%) 0.60
Family history of diabetes 13 (54%) 5 (26%) 0.80
Currently smokers 5 (21%) 12 (63%) 0.67
Echocardiography parameters
LVEF (%) 52.46 ±6.16 59.68 ±2.82 0.001
SIV (mm) 11.58 ±0.92 8.74 ±1.28 0.0001
PP (mm) 11.13 ±0.90 9.21 ±1.22 0.001
LVEDV (mL) 126.78 ±31.19 115.00 ±18.93 0.05
LVESV (mL) 58.57 ±17.20 40.05 ±6.32 0.002
LVM-I (g) 114.25 ±16.84 77.36 ±31.24 0.0001
Carotid echo-color Doppler parameters
CCA Sx (mm) 1.25 ±0.36 0.73 ±0.22 0.0001
ICA Sx (mm) 1.68 ±0.73 0.67 ±0.26 0.001
CCA Dx (mm) 1.30 ±0.39 0.56 ±0.28 0.001
ICA Dx (mm) 1.96 ±0.79 0.66 ±0.27 0.0001
foreachﬁeldatamagniﬁcationof1500x)fromMetSpatients
and healthy donors.
2.7. Statistical Analyses. Cytoﬂuorimetric results were statis-
tically analyzed by using the nonparametric Kolmogorov-
Smirnov test using Cell Quest Software. A least 20,000 events
were acquired. The median values of ﬂuorescence intensity
histograms were used to provide a semiquantitative analysis.
Statistical analyses of collected data were performed by using
Student’s t-test.
3. Results
3.1. Redox Balance. Considering that changes in the redox
statecancontributetothelossofRBCstructureandfunction
[8], two important parameters have been analyzed. We
measured the reactive oxygen species (ROS) production and
the total thiol content (essentially referred to as reduced glu-
tathione). However, no signiﬁcant diﬀerences were detected
in the ROS and total thiol production in RBCs from patients
with MetS in comparison with that from healthy donors
(Figures 1(a) and 1(b)). Furthermore, no gender diﬀerences
were observed.
3.2.MorphologicalAnalyses. ChangesofRBCviscosity,adhe-
siveness, and aggregability have been detected in many
human pathologic conditions. In particular, changes of
erythrocyte adhesiveness/aggregation and morphology have
been proposed as useful markers to detect inﬂammatory
conditions, plaque instability, and atheroma progression in
patients with coronary artery disease [18–20]. In order to
determine whether RBCs could be considered as biomarkers
of diagnostic or prognostic value in metabolic syndrome,
their morphology and adhesiveness/aggregation properties
were studied in cells from both healthy donors and in
patients with MetS. These analyses were carried out by
means of light microscopy (two representative micrographs
are shown in Figure 2(a)) and DIC microscopy evaluations
(not shown). A signiﬁcant increase of RBCs displaying
morphological alterations has been detected in samples
obtained from patients with MetS with respect to that from
healthy donors (Figure 2(b); note that the percentage of
altered RBCs, about 20%, was within the normal values)
[21]. In particular, RBCs with numerous surface protrusions
(acanthocytes) have been detected (arrows). Moreover, when
patient gender was taken into consideration, a diﬀerence
in terms of morphological alterations was detected. In
particular, the percentage of altered RBCs was higher in men4 International Journal of Cell Biology
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Figure 1: Cytoﬂuorimetric analysis of redox balance in the RBCs.
Histograms representing ﬂow cytometry analysis of (a) ROS
production and (b) intracellular content of reduced thiols. The
numbers are the mean ± SD of 40 HD (22 male and 18 female) and
56 MetS patients (31 male and 25 female). No signiﬁcant changes
were detectable in the ROS production and the GSH presence in
RBCs from MetS patients in comparison with that from healthy
donors. No gender diﬀerences were observed.
than in women with MetS. As expected, no gender diﬀerence
w a sd e t e c t e di nR B C sf r o mh e a l t h yd o n o r s( b l a c kh i s t o gra m s
in Figure 2(b)).
3.3. RBC Senescence and Death. The analysis of GA and
CD47 was carried out by both ﬂow cytometry (Figures
3(a)and4(a))andimmunoﬂuorescencemicroscopy(Figures
3(b) and 4(b)). These analyses clearly demonstrated that
the expression of GA and CD47 was substantially similar in
RBCs from patients with MetS and in those from healthy
donors (Figures 3(a) and 4(a)). However, when cells from
malesandfemaleswereanalyzedseparately,theexpressionof
these molecules was found signiﬁcantly (P < 0.05) diﬀerent:
lower in RBCs from men with MetS in comparison with
RBCs from women with MetS. Representative immuno-
ﬂuorescencemicrographsdisplayingGAandCD47positivity
in RBCs from healthy donors and men with MetS are
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Figure 2: Morphological analyses of RBCs. (a) Two representative
micrographs obtained by light microscopy displaying morpho-
logical alteration in RBCs from MetS patients (right panel) with
respect to those from healthy donors (left panel). Note the diﬀerent
aggregation features and the presence of surface protrusions
(arrows). (b) Morphometric analysis indicating the percentage of
altered RBCs in both HD and MetS patients. Data are the mean ±
SDof40HD(22maleand18female)and56MetSpatients(31male
and 25 female). When morphometric analyses were performed as
stated in Methods, a gender diﬀerence in terms of morphological
alteration was detectable in MetS patients. ∗P < 0.01, men with
MetS versus women with MetS.
shown in Figures 3(b) and 4(b). Moreover, as concerns PS
externalization, a signiﬁcantly higher translocation of PS to
the outer plasma membrane leaﬂet was detected in RBCs
from patients with MetS in comparison with those from
HD (Figure 5). Furthermore, a gender diﬀerence was also
appreciable. In fact, in RBCs from male patients with MetS,
the surface positivity for PS was twice that of controls,
whereasnodiﬀerence,intermofPSexternalization,hasbeen
detected between RBCs from HD females and RBCs from
females with Mets.
4. Discussion
Inthepresentpilotstudy,wefocusedourattentiononthered
blood cell as candidate biomarker of metabolic syndrome.
We also investigated about possible gender diﬀerences. We
analyzed in detail three diﬀerent “indicators” of RBC injury
and aging: glycophorin A, CD47, and phosphatidylserine. To
this aim, diverse blood determinants were evaluated in a lowInternational Journal of Cell Biology 5
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Figure 3: Glycophorin A analysis. (a) Histogram representing ﬂow
cytometryevaluationsofglycophorinA.Thenumbersrepresentthe
mean ± SD of 40 HD (22 male and 18 female) and 56 MetS patients
(31 male and 25 female). No changes, in terms of GA expression,
were detectable in RBCs from MetS patients with respect to those
from healthy donors. Conversely, a signiﬁcant (◦P < 0.05) decrease
of this protein was evident in RBCs from men with MetS ver-
sus healthy male donors. (b) Representative immunoﬂuorescence
micrographsdisplayingdiﬀerentarrangementandpositivityforGA
of RBCs from a healthy man and a man with MetS.
number (n = 56) of male and female patients that did not
display any sign of CAD. To be included in the study, these
patients should have at least 3 major criteria for MetS and
a pathologically abnormal carotid IMT. Carotid IMT was
in fact linked to many cardiovascular outcomes, including
cerebral and coronary events, and it has been proposed as
an index of subclinical atherosclerosis [22]. From a clinical
point of view, despite a similar incidence of risk factors
and IMT, men with MetS showed a signiﬁcantly higher LV
function and structure involvement in the absence of patent
CAD symptoms.
It is a matter of fact that circulating erythrocytes could
contribute to the pathogenesis of cardiovascular diseases
[2, 8, 23]. The shape maintenance as well as mechanical
deformability and elasticity of RBCs (7μm) is essential pre-
requisites for their circulation, speciﬁcally in small blood
vessels (about 5μm). If the RBC is altered, its aggregability
andadhesivepropertieschange,thuscontributingtovascular
damage [23]. In our study, we detected diﬀerences, in terms
ofcellaging,celladhesion,and/oraggregation,inRBCsfrom
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Figure 4: CD47 analysis. (a) Histogram representing ﬂow cytom-
etry evaluations of CD47. The numbers represent the mean ± SD
of 40 HD (22 male and 18 female) and 56 MetS patients (31 male
and 25 female). No changes, in terms of CD47 expression, were
detectable in RBCs from MetS patients with respect to those from
healthy donors. Conversely, a signiﬁcant (◦P < 0.05) decrease of this
p r o t e i nw a se v i d e n ti nR B C sf r o mm e nw i t hM e t Sv e r s u sh e a l t h y
male donors. (b) Representative immunoﬂuorescence micrographs
displaying diﬀerent arrangement and positivity for CD47 of RBCs
from a healthy man and a man with MetS.
MetS patients with respect to those of healthy donors. In
particular, we observed that the ability to pile was modiﬁed
in erythrocytes either from women or from men with MetS.
Moreover, they appeared to increase their adhesiveness to a
substrate. This was probably associated with the increased
PS externalization, a well-known marker of RBC aging and
death, that has been associated with increased cell adhesion
properties. In fact, studies have shown that RBC injury due
to energy or antioxidant depletion causes breakdown of
membrane phosphatidylserine asymmetry, with consequent
exposure of phosphatidylserine at the erythrocyte surface
(eryptosis) and binding to the phosphatidylserine receptors
at macrophages and liver Kupﬀer cells, which then engulf
anddegradetheaﬀectedRBCs[14].Locally,thesephagocytic
cells produce superoxide anion, which activates NF-κBa n d
c-JN, inﬂammatory signalling pathways that regulate cellular
transcriptional events, thereby leading to greater production
of TNF-α, IL-6, and other proinﬂammatory mediators [9].6 International Journal of Cell Biology
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Figure 5: Phosphatidylserine externalization. Histograms repre-
senting the percentage of annexin-V-positive RBCs. Data are the
mean ±SDof40HDs(22maleand18female)and56MetSpatients
(31 male and 25 female). An increased positivity was detectable in
RBCs from MetS patients with respect to those from healthy donors
(λ) •P<0.05. Analyzing separately RBCs from males and females,
a signiﬁcant increased positivity was detectable only in RBCs from
males with MetS with respect to healthy males. ◦P < 0.01.
This could be of relevance in the light of recent works
that describe the disparity of vascular cells from males and
from females in terms of their “basal” redox state and their
susceptibility to oxidative stress [24, 25] contributing to the
pathogenesis of vascular diseases [26].
Interestingly, as concerns gender, we also found signiﬁ-
cant diﬀerences (morphological alterations, aging-associated
moleculesGA,andadhesion-associatedmoleculesCD47and
PS). These results are in accord with several literature data
[23] that suggest RBC as real-time biomarkers of disease
progression and pathogenetic determinants in cardiovascu-
lar diseases. RBCs can in fact contribute to atherosclerotic
plaque formation [19] and can behave as prooxidants, thus
contributing to the pathogenetic mechanisms of vascu-
lar diseases [8]. For example, it has been demonstrated
that oxidized erythrocytes can represent potential sources
of systemic inﬂammation: the increase of exogenous or
endogenous CO2 deoxygenates haemoglobin favouring the
formation of methemoglobin [9].
Altogether the results of this pilot study are in line
with the literature data indicating erythrocytes as possible
biomarkers of vascular diseases [23]. We also hypothesize
that gender could represent a key variable in this issue [3].
Further studies appear, however, as mandatory in order to
assess if the gender-speciﬁc biomarkers analyzed here could
be detected in a larger study population, thus providing
useful insights for a gender-based management of MetS
progression.
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